发明名称 Therapeutic uses of SMR1 peptides
摘要 The invention relates to the therapeutic use of a SMR1-peptide or a pharmaceutically active amount of said SMR1-peptide, for the preparation of a therapeutic composition for preventing or treating diseases wherein a modulation of the activity of a membrane metallopeptidase, notably a membrane-zinc metallopeptidase, is sought, in a mammal, specifically in a human.
申请公布号 US2007054861(A1) 申请公布日期 2007.03.08
申请号 US20060594105 申请日期 2006.11.08
申请人 CENTRE NATIONAL DE LA RACHERCHE SCIENT 发明人 ROUGEOT CATHERINE;ROUGEON FRANCOIS
分类号 A61K38/55;G01N33/50;A61K38/00;A61K38/22;A61K45/00;A61P1/12;A61P9/10;A61P9/12;A61P13/02;A61P25/00;A61P25/04;A61P25/14;A61P25/18;A61P25/20;A61P25/22;A61P25/24;A61P25/28;A61P27/00;A61P29/00;A61P31/04;A61P31/12;A61P35/00;A61P43/00;C07K14/575;C12N9/99;C12Q1/02;C12Q1/37;G01N33/15;G01N33/566 主分类号 A61K38/55
代理机构 代理人
主权项
地址